Helicobacter pylori, ethnicity, and the gastroesophageal reflux disease spectrum: A study from the East

Helicobacter

Volumn 12, Issue 2, 2007, Pages 177-183

  Rajendra, Shanmugarajah ^a,c   Ackroyd, Roger ^b   Robertson, Iain K ^c   Ho, Jacqueline J ^a   Karim, Norain ^d   Kutty, Kannan M ^e  

^a UNIVERSITI KUALA LUMPUR   (Malaysia)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF TASMANIA   (Australia)

^d HOSPITAL RAJA PERMAISURI BAINUN   (Malaysia)

^e UNIVERSITI TEKNOLOGI MARA   (Malaysia)

Author keywords

Asian; Barrett's esophagus; cagA; Corpus atrophy; Ethnicity; Gastritis; Gastroesophageal reflux disease; Helicobacter pylori

Indexed keywords

CAGA PROTEIN;

ADULT; ARTICLE; ASIAN; ATROPHY; BARRETT ESOPHAGUS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNICITY; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INDIAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; STOMACH BIOPSY;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALAYSIA; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES;

HELICOBACTER PYLORI;

EID: 33847054263     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2007.00489.x     Document Type: Article

References (39)

1. Lord RV, Frommer DJ, Inder S, et al. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma. Aust NZ Surg 2000;70:26-33.
2. Hackelsberger A, Schultze V, Gunther T, et al. The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: a case-control study. Eur J Gastroenterol Hepatol 1998;10:465-8.
3. Werdmuller BF, Loffeld RJ. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci 1997;42:103-5.
4. Wu JC, Sung JJ, Ng EK, et al. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East. Am J Gastroenterol 1999;94:1790-4.
5. Varanasi RV, Fantry GT, Wilson KT. Decreased prevalence of H. pylori infection in gastroesophageal reflux disease. Helicobacter 1998;3:188-94.
6. Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 2001;1:330-4.
7. O'Connor HJ. Helicobacter pylori and gastro-oesophageal reflux disease - clinical implications and management. Aliment Pharmacol Ther 1999;13:117-27.
8. Malfertheiner P, Gerards C. Helicobacter pylori infection and gastro-oesophageal reflux disease: coincidence or association? Baillieres Best Pract Res Clin Gastroenterol 2000;14:731-41.
9. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588-90.
10. Vaezi MF, Falk GW, Peek RM, et al. CagA-positive strains of Helicobacter pylori may protect against Barrett's oesophagus. Am J Gastroenterol 2000;95:2206-11.
11. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998;115:50-7.
12. Wu AH, Crabtree JE, Bernstein L, et al. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Intl J Cancer 2003;103:815-21.
13. Rajendra S, Alahuddin S. Racial differences in the prevalence of heartburn. Aliment Pharmacol Ther 2004;19:375-6.
14. Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic oesophagitis and Barrett's oesophagus: the long and short of it all. Dig Dis Sci 2004;49:237-42.
15. Rosaida MS, Goh KL. Gastroesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy-based study. Eur J Gastroenterol Hepatol 2004;16:495-501.
16. Rajendra S, Ackroyd R, Mohan C. South Asian origin as a risk factor for GERD. Aliment Pharmacol Ther 2005;22:75-6.
17. Rajendra S, Ackroyd R, Murad S, et al. HLA determinants of susceptibility to Barrett's oesophagus in Asians: a preliminary report. Aliment Pharmacol Ther 2005;21:1377-83.
18. Shaari AR. Population distribution and basic demographic characteristics. In: The 2000 Population and Housing Census of Malaysia. Putrajaya, Malaysia: Department of Statistics, 2000.
19. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of esophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-80.
20. Xia HHX, Kalantar JS, Mitchell HM, et al. Can Helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia? Aliment Pharmacol Ther 2000;15:615-24.
21. Goh KL, Parasakthi N, Peh SC, et al. The rapid urease test in the diagnosis of Helicobacter pylori infection. Singapore Med J 1994;35:161-2.
22. Leung WK, Chow TP, Ng EKW, et al. Validation of a new immunoblot assay for the diagnosis of Helicobacter pylori in the Asian population. Aliment Pharmacol Ther 2001;15:423-8.
23. Wong CM, Rajendra S, Aiyar S, et al. Evaluation of a new immunoblot assay for the diagnosis of Helicobacter pylori infection in a multiethnic Asian patient population. Mal Med J 2005;60:12 (Abstract).
24. Loffeld RJ, Ten Tije BJ, Arends JW. Prevalence and significance of Helicobacter pylori in patients with Barrett's oesophagus. Am J Gastroenterol 1992;87:1598-600.
25. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996;20:1161-81.
26. Goh KL. Prevalence of and risk factors for Helicobacter pylori infection in a multi-racial dyspeptic Malaysian population undergoing endoscopy. J Gastroenterol Hepatol 1997;12:S29-35.
27. Goh KL, Parasakthi N. The racial cohort phenomenon. seroepidemiology of Helicobacter pylori infection in a multiracial South-East Asian country. Eur J Gastroenterol Hepatol 2001;13:177-83.
28. Queiroz DMM, Rocha GA, Oliveira CA, et al. Role of corpus gastritis and cagA-positive Helicobacter pylori infection in reflux oesophagitis. J Clin Microbiol 2002;40:2849-53.
29. Kuipers EJ, Perez-Perez GI, Meuwissen GM, et al. Helicobacter pylori and atrophic gastritis: Importance of the cagA status. J Natl Cancer Inst 1995;87:1777-80.
30. Lai CH, Poon SK, Chen YC, et al. Lower prevalence of Helicobacter pylori infection with vacAs1a, cagA-positive, and babA2-positive genotype in erosive reflux esophagitis disease. Helicobacter 2005;10:577-85.
31. Maeda S, Ogura K, Yoshida H, et al. Major virulence factors, VacA, and cagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 1998;42:338-43.
32. Yamaji Y, Mitsushima T, Ikuma H, et al. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut 2001;49:335-40.
33. Wu JCY, Sung JJY, Chan FKL, et al. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000;14:427-32.
34. Malfertheiner P, Peitz U. The interplay between Helicobacter pylori, gastro-oesophageal reflux disease and intestinal metaplasia. Gut 2005;54 (Suppl. 1):i13-20.
35. Kudo M, Gutierrez O, El-Zimaity HMT, et al. CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer. J Clin Pathol 2005;58:259-62.
36. Kahliras PJ, Gupta RR. The effect of cigarette smoking in salivation and oesophageal acid clearance. J Lab Clin Med 1989;114:431-8.
37. Westhoff B, Brotze S, Weston A, et al. The frequency of Barrett's oesophagus in high-risk patients with chronic GERD. Gastrointest Endosc 2005;61:226-31.
38. Cameron AJ, Lomboy CT. Barrett's oesophagus: age, prevalence and extent of columnar epithelium. Gastroenterology 1992;103:1241-5.
39. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol 1996;91:1785-8.